392 related articles for article (PubMed ID: 31270299)
1. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
[TBL] [Abstract][Full Text] [Related]
3. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
[No Abstract] [Full Text] [Related]
4. Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
Deguchi-Horiuchi H; Ito M; Takahashi S; Kousaka K; Hisakado M; Fukata S; Kudo T; Nishihara E; Nishikawa M; Miyauchi A; Akamizu T
Endocr J; 2024 Apr; 71(4):373-381. PubMed ID: 38296546
[TBL] [Abstract][Full Text] [Related]
5. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
6. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
[TBL] [Abstract][Full Text] [Related]
7. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
[TBL] [Abstract][Full Text] [Related]
8. Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
Takahashi S; Ito M; Masaki Y; Hada M; Minakata M; Kohsaka K; Nakamura T; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2021 Mar; 68(3):353-360. PubMed ID: 33239477
[TBL] [Abstract][Full Text] [Related]
9. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
10. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
11. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.
Hoermann R; Midgley JE; Giacobino A; Eckl WA; Wahl HG; Dietrich JW; Larisch R
Clin Endocrinol (Oxf); 2014 Dec; 81(6):907-15. PubMed ID: 24953754
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
Na YM; Cho JS; Park MH
Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
[TBL] [Abstract][Full Text] [Related]
14. Prediction of thyroid hormone supplementation after thyroid lobectomy.
Lee DY; Seok J; Jeong WJ; Ahn SH
J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
[TBL] [Abstract][Full Text] [Related]
15. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
Altuntaş SÇ; Hocaoğlu Ç
Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract][Full Text] [Related]
17. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
Tariq A; Wert Y; Cheriyath P; Joshi R
South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
[TBL] [Abstract][Full Text] [Related]
18. Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study.
Ito M; Takahashi S; Okazaki-Hada M; Minakata M; Kohsaka K; Nakamura T; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamiuzu T; Miyauchi A
Thyroid Res; 2022 May; 15(1):9. PubMed ID: 35534833
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.
Gullo D; Latina A; Frasca F; Le Moli R; Pellegriti G; Vigneri R
PLoS One; 2011; 6(8):e22552. PubMed ID: 21829633
[TBL] [Abstract][Full Text] [Related]
20. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
